Terns Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TERN and other ETFs, options, and stocks.About TERN
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program.
TERN Key Statistics
Stock Snapshot
As of today, Terns Pharmaceuticals(TERN) shares are valued at $52.67. The company's market cap stands at 5.61B, with a P/E ratio of -51.06.
On 2026-03-31, Terns Pharmaceuticals(TERN) stock moved within a range of $52.67 to $52.89. With shares now at $52.67, the stock is trading +0.0% above its intraday low and -0.4% below the session's peak.
Trading volume for Terns Pharmaceuticals(TERN) stock has reached 12.81M, versus its average volume of 14.73M.
Over the past 52 weeks, Terns Pharmaceuticals(TERN) stock has traded between a high of $53.19 and a low of $1.87.
Over the past 52 weeks, Terns Pharmaceuticals(TERN) stock has traded between a high of $53.19 and a low of $1.87.
Analyst ratings
70%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.